Published: Guidance, quality standards and advice

Showing 31 to 39 of 39

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip	TA304	26 February 2014	26 February 2014
Canakinumab for treating systemic juvenile idiopathic arthritis (terminated appraisal)	TA302	27 November 2013	27 November 2013
Tocilizumab for the treatment of rheumatoid arthritis	TA247	22 February 2012	22 February 2012
Tocilizumab for the treatment of systemic juvenile idiopathic arthritis	TA238	14 December 2011	14 December 2011
Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs	TA225	22 June 2011	22 June 2011
Golimumab for the treatment of psoriatic arthritis	TA220	27 April 2011	27 April 2011
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor	TA195	25 August 2010	25 August 2010
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis	TA199	25 August 2010	25 August 2010
Artificial metacarpophalangeal and interphalangeal joint replacement for end-stage arthritis	HTG66	23 February 2005	23 February 2005